Blood Test for Early Detection of Bowel Polyps and Colorectal Cancer
Studies a blood test to find colon polyps and colorectal cancer early.
Plain-language title generated from the registry record
Registry title: Early Detection of Advanced Adenomas and Colorectal Cancer
Key facts
- Where
- Barcelona, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a colonoscopy when their blood was taken. It tests a blood test for early detection of advanced adenomas and colorectal cancer.
- Age
- 18 Years or older
- Sex
- All sexes can join.
- Disease stage
- The record does not set one stage. It lists colorectal polyps, adenomas, and colorectal cancer stages I to IV.
- Earlier treatment
- At least one blood sample must have been taken before any treatment meant to remove all of the disease.
Main reasons for not taking part
- Hereditary colorectal cancer syndromes (found through genetic testing)
- Inflammatory bowel diseases
- No written informed consent
Read by machine on 12 November 2026.
Where in Spain
- Barcelona UniversityBarcelona, SpainContact: Francesc Balaguer, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- City of Hope Medical Center
- Trial code
- NCT06342440
- Record updated
- 7 July 2026
- Original description
This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.Read full original descriptionShow less
A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer
This study aims to develop a highly sensitive, specific, and cost-effective blood assay for early detection of colorectal adenomas and cancer, using advanced machine learning and state-of-the-art biological analyses.
Inclusion: All individuals included in the study need to have had a colonoscopy at the time of blood sampling; Received standard diagnostic and staging (as necessary) procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment; Received standard pathological and endoscopic diagnosis and assessment for cohort assignment.
Exclusion: Hereditary colorectal cancer syndromes (identified through genetic testing); Inflammatory bowel diseases; Lack of written informed consent.